Jane Street
MEDP icon

Jane Street’s Medpace MEDP Stock Holding History

Jane Street’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$792K Sell
1,495
-166
-10% -$76.6K ﹤0.01% 7021
2026
Q1 		$798K Sell
1,661
-26,628
-94% -$13.6M ﹤0.01% 6983
2025
Q4 		$15.9M Sell
28,289
-26,976
-49% -$15.3M ﹤0.01% 1819
2025
Q3 		$28.4M Sell
55,265
-256,513
-82% -$112M ﹤0.01% 1343
2025
Q2 		$97.9M Buy
311,778
+268,651
+623% +$80.7M 0.02% 472
2025
Q1 		$13.1M Buy
43,127
+30,497
+241% +$10.3M ﹤0.01% 1680
2024
Q4 		$4.2M Sell
12,630
-394
-3% -$134K ﹤0.01% 2914
2024
Q3 		$4.35M Buy
13,024
+4,468
+52% +$1.7M ﹤0.01% 3088
2024
Q2 		$3.52M Sell
8,556
-9,367
-52% -$3.71M ﹤0.01% 3535
2024
Q1 		$7.24M Sell
17,923
-12,978
-42% -$4.56M ﹤0.01% 2152
2023
Q4 		$9.47M Sell
30,901
-29,754
-49% -$8.03M ﹤0.01% 2017
2023
Q3 		$14.7M Sell
60,655
-7,575
-11% -$1.94M ﹤0.01% 1378
2023
Q2 		$16.4M Buy
68,230
+60,505
+783% +$12.6M 0.01% 1414
2023
Q1 		$1.45M Sell
7,725
-11,533
-60% -$2.39M ﹤0.01% 4354
2022
Q4 		$4.09M Buy
19,258
+8,558
+80% +$1.71M ﹤0.01% 2762
2022
Q3 		$1.68M Sell
10,700
-13,980
-57% -$2.23M ﹤0.01% 4500
2022
Q2 		$3.69M Buy
24,680
+12,769
+107% +$1.85M ﹤0.01% 3119
2022
Q1 		$1.95M Buy
11,911
+3,372
+39% +$556K ﹤0.01% 4815
2021
Q4 		$1.86M Sell
8,539
-1,198
-12% -$251K ﹤0.01% 4622
2021
Q3 		$1.84M Buy
9,737
+4,748
+95% +$866K ﹤0.01% 4640
2021
Q2 		$881K Buy
4,989
+1,088
+28% +$188K ﹤0.01% 6091
2021
Q1 		$640K Sell
3,901
-10,029
-72% -$1.53M ﹤0.01% 6347
2020
Q4 		$1.94M Buy
13,930
+11,481
+469% +$1.45M ﹤0.01% 3535
2020
Q3 		$274K Sell
2,449
-1,653
-40% -$191K ﹤0.01% 6019
2020
Q2 		$382K Buy
+4,102
New +$349K ﹤0.01% 5478
2019
Q4 		– Sell
-2,736
Closed -$230K – 5483
2019
Q3 		$230K Buy
+2,736
New +$207K ﹤0.01% 4483
2016
Q4 		– Sell
-32,771
Closed -$979K – 4380
2016
Q3 		$979K Buy
+32,771
New +$957K ﹤0.01% 1999

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Jane Street's MEDP Position: Q2 2026 in Review

Jane Street reduced its Medpace (MEDP) stake by 10% in Q2 2026, selling an estimated $76.6K and leaving 1,495 shares worth $792K. The position accounts for ﹤0.01% of the portfolio, ranked #7021.

Jane Street first reported a position in MEDP in Q3 2016 and has held it in 27 quarters since. The position peaked at $97.9M in Q2 2025. 661 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Jane Street held 1,495 shares of Medpace worth $792K as of Q2 2026.
  • Jane Street sold 166 Medpace shares in Q2 2026, an estimated $76.6K.
  • Medpace made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #7021 holding.
  • Jane Street first reported a position in Medpace in Q3 2016 and has held it in 27 quarters since.
  • Jane Street's Medpace position peaked at $97.9M in Q2 2025.
  • 661 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.